Etanercept in patients with moderate to severe plaque psoriasis: a retrospective case cohort analysis

被引:0
|
作者
Perera, G. [1 ]
Fonia, A. [1 ]
Smith, C. [1 ]
Barker, J. N. W. N. [1 ]
机构
[1] St Johns Inst Dermatol, London, England
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:26 / 27
页数:2
相关论文
共 50 条
  • [1] Effects of etanercept treatment on lipid profile in patients with moderate-to-severe chronic plaque psoriasis: a retrospective cohort study
    Lestre, Sara
    Diamantino, Filipa
    Veloso, Luis
    Fidalgo, Ana
    Ferreira, Ana
    EUROPEAN JOURNAL OF DERMATOLOGY, 2011, 21 (06) : 916 - 920
  • [2] Switching to adalimumab in patients with moderate to severe psoriasis who have failed on etanercept: a retrospective case cohort study
    Woolf, R. T.
    Smith, C. H.
    Robertson, K.
    Barker, J. N. W. N.
    BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 (04) : 889 - 892
  • [3] Efficacy and safety of etanercept in moderate to severe plaque psoriasis
    Tunca, M.
    Koc, E.
    Akar, A.
    Kurumlu, Z.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2007, 21 : 53 - 53
  • [4] Long-term Management of Moderate to Severe Plaque Psoriasis Patients With Etanercept: A Case Series
    Bourcier, Marc
    Papp, Kim Alexander
    Gulliver, Wayne P.
    Poulin, Yves
    Barber, Kirk
    Poulin-Costello, Melanie
    Shelton, Jennifer
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2015, 19 (06) : 561 - 569
  • [5] Pharmacokinetics, Immunogenicity, and Efficacy of Etanercept in Pediatric Patients With Moderate to Severe Plaque Psoriasis
    Langley, Richard G.
    Kasichayanula, Sree
    Trivedi, Mona
    Aras, Girish A.
    Kaliyaperumal, Arunan
    Yuraszeck, Theresa
    Gibbs, John
    Gibbs, Megan
    Kricorian, Greg
    Paller, Amy S.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (03): : 340 - 346
  • [6] Cost per responder analysis of ustekinumab and etanercept for moderate to severe plaque psoriasis
    Martin, Silas
    Feldman, Steven R.
    Augustin, Matthias
    Szapary, Philippe
    Schenkel, Brad
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2011, 22 (03) : 138 - 143
  • [7] Etanercept therapy for moderate to severe plaque psoriasis with involvement of the scalp
    Bagel, Jerry
    Kricorian, Gregory
    Klekotka, Paul
    Tyring, Stephen
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB150 - AB150
  • [8] Safety update of etanercept treatment for moderate to severe plaque psoriasis
    Campanati, Anna
    Diotallevi, Federico
    Martina, Emanuela
    Paolinelli, Matteo
    Radi, Giulia
    Offidani, Annamaria
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (04) : 439 - 448
  • [9] Baseline characteristics of patients with moderate to severe plaque psoriasis: post-hoc analysis of response to etanercept
    Gisondi, Paolo
    Girolomoni, Giampiero
    de Vlam, Kurt
    Al Hammadi, Anwar
    Carneiro, Sueli
    Arenberger, Petr
    Gallo, Gaia
    Jones, Heather
    Hsu, Ming-Ann
    Ferdousi, Tahmina
    Szumski, Annette
    Chhabra, Amit
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S26 - S26
  • [10] Characterization of etanercept pharmacokinetics, immunogenicity, and efficacy in pediatric patients with moderate to severe plaque psoriasis
    Langley, Richard G.
    Kasichayanula, Sree
    Trivedi, Mona
    Aras, Gary
    Kaliyaperumal, Arunan
    Yuraszeck, Theresa
    Gibbs, Megan
    Kricorian, Greg
    Paller, Amy S.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB67 - AB67